Single-center series and systematic review of randomized controlled trials of malignancies in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis receiving anti-tumor necrosis factor alpha therapy: Is there a need for more comprehensive screening procedures?

MLA

Nannini C, et al. “Single-Center Series and Systematic Review of Randomized Controlled Trials of Malignancies in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis Receiving Anti-Tumor Necrosis Factor Alpha Therapy: Is There a Need for More Comprehensive Screening Procedures?” Arthritis & Rheumatism: Arthritis Care & Research, vol. 61, no. 6, June 2009, pp. 801–12. EBSCOhost, https://doi.org/10.1002/art.24506.

APA

Nannini C, Cantini F, Niccoli L, Cassarà E, Salvarani C, Olivieri I, & Lally EV. (2009). Single-center series and systematic review of randomized controlled trials of malignancies in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis receiving anti-tumor necrosis factor alpha therapy: Is there a need for more comprehensive screening procedures? Arthritis & Rheumatism: Arthritis Care & Research, 61(6), 801–812. https://doi.org/10.1002/art.24506

Chicago

Nannini C, Cantini F, Niccoli L, Cassarà E, Salvarani C, Olivieri I, and Lally EV. 2009. “Single-Center Series and Systematic Review of Randomized Controlled Trials of Malignancies in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis Receiving Anti-Tumor Necrosis Factor Alpha Therapy: Is There a Need for More Comprehensive Screening Procedures?” Arthritis & Rheumatism: Arthritis Care & Research 61 (6): 801–12. doi:10.1002/art.24506.